Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Effects of Coronavirus Disease 2019 (Covid-19) on Peripheral Blood Lymphocytes and Their Subsets in Children: Imbalanced Cd4+/Cd8+ T Cell Ratio and Disease Severity
Farhad Shahi

Associate Professor of Hematology & Oncology

Department Internal Medicine

School of Medicine

Cancer Institute

Tehran University of Medical Sciences

Related Documents
1. The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran, International Journal of Hematology-Oncology and Stem Cell Research (2023)
All Documents
1. Onychomycosis Among Cancer Patients Undergoing Chemotherapy in Tehran, Iran: A Cross-Sectional Study, Iranian Journal of Microbiology (2025)
2. Proposed Method for Economic Evaluation Based on Basket Trials: A Case Study of Pembrolizumab, Expert Review of Pharmacoeconomics and Outcomes Research (2025)
3. Prediction of Novel Biomarkers for Gastric Intestinal Metaplasia and Gastric Adenocarcinoma Using Bioinformatics Analysis, Heliyon (2024)
4. Pulmonary Hypertension in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
5. Hyepereosiniphilic Syndrome and Covid-19: 2 Case Reports, Journal of Cardiothoracic Surgery (2023)
6. Pharmaceutical and Clinical Studies of Celecoxib Topical Hydrogel for Management of Chemotherapy-Induced Hand-Foot Syndrome, Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
7. Tamoxifen Retinopathy, Survey of Ophthalmology (2023)
8. The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran, International Journal of Hematology-Oncology and Stem Cell Research (2023)
9. A Post-Marketing Surveillance Study to Evaluate the Safety Profile of Alvotereⓡ (Docetaxel) in Iranian Patients Diagnosed With Different Types of Cancers Receiving Chemotherapy, Current Therapeutic Research - Clinical and Experimental (2022)
10. A Randomized, Double-Blind, Phase Iii, Non-Inferiority Clinical Trial Comparing the Efficacy and Safety of Ta4415v (A Proposed Trastuzumab Biosimilar) and Herceptin (Trastuzumab Reference Product) in Her2-Positive Early-Stage Breast Cancer Patients, BMC Pharmacology and Toxicology (2022)
11. Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial, BMC Cancer (2022)
12. Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial, BMC Cancer (2022)
13. Correction: Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial (Bmc Cancer, (2022), 22, 1, (960), 10.1186/S12885-022-09895-5), BMC Cancer (2022)
14. Correction: Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial (Bmc Cancer, (2022), 22, 1, (960), 10.1186/S12885-022-09895-5), BMC Cancer (2022)
15. Post-Marketing Surveillance of a Generic Oxaliplatin (Alvoxalⓡ) in Iranian Patients With Cancer, Current Therapeutic Research - Clinical and Experimental (2022)
16. Assessing Physicians’ Performance When Telling the Truth to Patients Diagnosed With Cancer, Journal of Advances in Medical and Biomedical Research (2021)
17. Efficacy of Topical Lawsonia Inermis L. (Henna) Hydrogel in Fluorouracil-Induced Hand-Foot Syndrome: A Pilot Randomized Double-Blind Placebo-Controlled Clinical Trial, Cutaneous and Ocular Toxicology (2021)
18. Cholangiocarcinoma: State of the Art, Journal of Gastrointestinal Cancer (2020)
19. Combination Antifungal Therapy Without Craniotomy in an Immunocompromised Patient With Rhino-Orbito-Cerebral Mucormycosis: A Case Report, Caspian Journal of Internal Medicine (2020)
20. Conflict of Interest: Are Iranian Breast Cancer Specialists Prone to It?, Asian Pacific Journal of Cancer Prevention (2020)
21. Effectiveness of Acupuncture Treatment on Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized, Assessor-Blinded, Controlled Trial, Pain Research and Management (2020)
22. Identification and Validation of Stage-Associated Pbmc Biomarkers in Breast Cancer Using Ms-Based Proteomics, Frontiers in Oncology (2020)
23. Management Policies of Breast Cancer Surgery, Chemotherapy and Radiotherapy During Covid-19 Outbreak in Iran, World Cancer Research Journal (2020)
24. Modifications in Breast Cancer Guidelines in Covid-19 Pandemic; an Iranian Consensus, Archives of Breast Cancer (2020)
25. The Predictive Value of Kras and Nras Mutations in Metastatic Colorectal Cancer, Medical Journal of the Islamic Republic of Iran (2020)
26. Assessment of Carvedilol Therapy in Prevention of Heart Failure in Her2 Positive Breast Cancer Patients Receiving Trastuzumab, Acta Medica Iranica (2019)
27. Effectiveness of Integrating Simulation With Art-Based Teaching Strategies on Oncology Fellows’ Performance Regarding Breaking Bad News, Journal of Cancer Education (2019)
28. Successful Desensitization of a Patient With Cetuximab Hypersensitivity: A Case Report, Journal of Oncology Pharmacy Practice (2019)
29. A Survey of Infection in Allogenic Hematopoietic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia, International Journal of Organ Transplantation Medicine (2018)
30. Liver Fibrosis Alleviation After Co-Transplantation of Hematopoietic Stem Cells With Mesenchymal Stem Cells in Patients With Thalassemia Major, Annals of Hematology (2018)
31. The Effect of Aromatherapy With Peppermint Essential Oil on Nausea and Vomiting in the Acute Phase of Chemotherapy in Patients With Breast Cancer, Journal of Babol University of Medical Sciences (2018)
32. Development of the First Guideline for Professional Conduct in Medical Practice in Iran, Archives of Iranian Medicine (2017)
33. Differentiating and Categorizing of Liposarcoma and Synovial Sarcoma Neoplasms by Fluorescence in Situ Hybridization, Iranian Journal of Pathology (2017)
34. Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report From Cancer Institute of Iran, International Journal of Hematology-Oncology and Stem Cell Research (2017)
35. A Patient With Multiple Myeloma and Renal Cell Carcinoma, International Journal of Hematology-Oncology and Stem Cell Research (2016)
36. Contextualization and Validation of the Interprofessional Collaborator Assessment Rubric (Icar) Through Simulation: Pilot Investigation, Medical Journal of the Islamic Republic of Iran (2016)
37. Preliminary Results of Allogenic Hematopoietic Stem Cell Transplantation of Non-M3 Acute Myeloid Leukemia, Iranian Journal of Blood and Cancer (2016)
38. Undergraduate Medical Education Programme Renewal: A Longitudinal Context, Input, Process and Product Evaluation Study, Perspectives on Medical Education (2016)
39. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report From a Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial, Phytotherapy Research (2015)
40. Trastuzumab-Induced Cardiomyopathy Evaluation by Combined Echocardiography and Biomarkers in Patients With Breast Cancer, Iranian Heart Journal (2015)
41. Urine Ratio of Neutrophil Gelatinase-Associated Lipocalin to Creatinine As a Marker for Early Detection of Cisplatinassociated Nephrotoxicity, Iranian Journal of Kidney Diseases (2015)